Literature DB >> 9111060

A 20-nucleotide (A + U)-rich element of beta2-adrenergic receptor (beta2AR) mRNA mediates binding to beta2AR-binding protein and is obligate for agonist-induced destabilization of receptor mRNA.

B G Tholanikunnel1, C C Malbon.   

Abstract

The Mr 35,000 beta-adrenergic receptor mRNA-binding protein, termed betaARB protein, is induced by beta-adrenergic agonists and binds to beta2-receptor mRNAs that display agonist-induced destabilization. A cognate sequence in the mRNA was identified previously that provides for betaARB protein binding in vitro. In the present work, the sequence established in vitro for binding of betaARB protein to hamster beta2-adrenergic receptor mRNA was probed in vivo by site-directed mutagenesis of the 3'-untranslated region and expression in Chinese hamster ovary cells. A 20-nucleotide, (A + U)-rich region in the 3'-untranslated region consisting of an AUUUUA hexamer flanked by defined U-rich regions constitutes the binding domain for betaARB protein. U to G substitution in the hexamer region attenuates the binding of betaARB protein, whereas U to G substitution of hexamer and flanking U-rich domains abolishes binding of betaARB protein and stabilizes beta2-adrenergic receptor mRNA levels in transfectant clones challenged with either isoproterenol or cyclic AMP. These results demonstrate that binding of betaARB protein to the 20-nucleotide, (A + U)-rich domain mediates the agonist and cyclic AMP-induced mRNA decay of G protein-linked receptors, such as the beta2-adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9111060     DOI: 10.1074/jbc.272.17.11471

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 2.  Structure, function and regulation of gonadotropin receptors - a perspective.

Authors:  K M J Menon; Bindu Menon
Journal:  Mol Cell Endocrinol       Date:  2012-02-09       Impact factor: 4.102

Review 3.  Molecular regulation of gonadotropin receptor expression: relationship to sterol metabolism.

Authors:  K M J Menon; B Menon; L Wang; T Gulappa; M Harada
Journal:  Mol Cell Endocrinol       Date:  2010-06-04       Impact factor: 4.102

4.  CRM 1-mediated degradation and agonist-induced down-regulation of beta-adrenergic receptor mRNAs.

Authors:  Ying Bai; Huafei Lu; Curtis A Machida
Journal:  Biochim Biophys Acta       Date:  2006-08-22

5.  Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.

Authors:  C Zierold; J A Mings; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

6.  The 3'-untranslated region length and AU-rich RNA location modulate RNA-protein interaction and translational control of β2-adrenergic receptor mRNA.

Authors:  Kothandharaman Subramaniam; Karthikeyan Kandasamy; Kusumam Joseph; Eleanor K Spicer; Baby G Tholanikunnel
Journal:  Mol Cell Biochem       Date:  2011-03-03       Impact factor: 3.396

7.  Reciprocal regulation of beta-adrenergic receptor mRNA stability by mitogen activated protein kinase activation and inhibition.

Authors:  Violetta V Headley; Rasheeda Tanveer; Scott M Greene; Adam Zweifach; J David Port
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

8.  Identification and characterization of proteins that selectively interact with the LHR mRNA binding protein (LRBP) in rat ovaries.

Authors:  Lei Wang; Thippeswamy Gulappa; K M J Menon
Journal:  Biochim Biophys Acta       Date:  2010-02-16

9.  Correlation between intrinsic mRNA stability and the affinity of AUF1 (hnRNP D) and HuR for A+U-rich mRNAs.

Authors:  Burns C Blaxall; Aldo Pende; Steven C Wu; J David Port
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

10.  Alterations in vasodilator-stimulated phosphoprotein (VASP) phosphorylation: associations with asthmatic phenotype, airway inflammation and beta2-agonist use.

Authors:  Annette T Hastie; Min Wu; Gayle C Foster; Gregory A Hawkins; Vikas Batra; Katherine A Rybinski; Rosemary Cirelli; James G Zangrilli; Stephen P Peters
Journal:  Respir Res       Date:  2006-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.